Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Male

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
BMJ Paediatrics Open|March 1, 2019
Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European surveyCristina Castro Díez, Feras Khalil, Holger Schwender, et al.
Hamostaseologie|November 13, 2018
Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia RegistryJudit Rejtő, Sylvia Reitter-Pfoertner, Sylvia Kepa, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisC Heleen van Ommen, Manuela Albisetti, Mohir Bhatt, et al.
Blood Advances|August 25, 2022
Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-JrJoseph S Palumbo, Anthonie W A Lensing, Leonardo R Brandão, et al.
Pharmaceutics|June 24, 2022
Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)Stephanie Laeer, Willi Cawello, Bjoern B Burckhardt, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2022
Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and HemostasisGary M Woods, Leslie Raffini, Leonardo R Brandão, et al.
Blood|December 18, 2014
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humansChristoph J Hofbauer, Shawn F J Whelan, Maria Hirschler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2023
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centresSusanna Ranta, Jayashree Motwani, Jan Blatny, et al.
Journal of the American Heart Association|March 20, 2026
Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial SubstudyGhada A Aborkhees, Amy J Barr, Kevin Dietrich, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart DiseaseAntoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
BMJ Paediatrics Open|March 1, 2019
Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European surveyCristina Castro Díez, Feras Khalil, Holger Schwender, et al.
Hamostaseologie|November 13, 2018
Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia RegistryJudit Rejtő, Sylvia Reitter-Pfoertner, Sylvia Kepa, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2021
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasisC Heleen van Ommen, Manuela Albisetti, Mohir Bhatt, et al.
Blood Advances|August 25, 2022
Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-JrJoseph S Palumbo, Anthonie W A Lensing, Leonardo R Brandão, et al.
Pharmaceutics|June 24, 2022
Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)Stephanie Laeer, Willi Cawello, Bjoern B Burckhardt, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2022
Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and HemostasisGary M Woods, Leslie Raffini, Leonardo R Brandão, et al.
Blood|December 18, 2014
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humansChristoph J Hofbauer, Shawn F J Whelan, Maria Hirschler, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2023
Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centresSusanna Ranta, Jayashree Motwani, Jan Blatny, et al.
Journal of the American Heart Association|March 20, 2026
Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial SubstudyGhada A Aborkhees, Amy J Barr, Kevin Dietrich, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart DiseaseAntoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
Pageof 14